Pulling SEC filings + quote and writing the call…

Palomar Holdings, Inc.
Next earnings Aug 3, 2026 · consensus $2.28 EPS, $633M rev
Last earnings -0.9% on 2026-05-06
Specialty insurer compounding GWP at ~55% CAGR with 22.5% margins and 20.9% ROE — trading at a reasonable 16.6x earnings.
Revenue $876M · FY2025
Quality fundamentals and an attractive price line up (~116% below fair value) — the rarer case where both the business and the entry look good.
Palomar is a high-quality specialty P&C compounder hiding in plain sight. The numbers are exceptional: FY2025 revenue grew 58.2% to $876M, net income jumped 67.6% to $197M, and diluted EPS rose 60% to $7.17. Operating cash flow of $409M (+56.7%) materially exceeds reported earnings, and capex is a rounding error ($137K) — this is a capital-light business converting underwriting profits to cash. The MD&A confirms the scale of the franchise: gross written premiums hit $2.0B in 2025, a ~55% CAGR from $16.6M at inception in 2014, and the company has been profitable every year since 2016 with a 46% net income CAGR over the same period. ROE of 20.9% on a $943M equity base is best-in-class for the industry.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $248M | $327M | $376M | $554M | $876M |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $45.8M | $52.2M | $79.2M | $118M | $197M |
| Diluted EPS | $1.76 | $2.02 | $3.13 | $4.48 | $7.17 |
| Net margin | 18.5% | 15.9% | 21.1% | 21.2% | 22.5% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Reg FD/investor update with exhibits; non-earnings disclosure to shareholders
Annual meeting vote results and board/officer changes disclosed
Q1 2026 10-Q reflecting continued premium growth and FIA contribution
Q1 2026 earnings release; continues strong growth trajectory from FY2025
2026 proxy: director slate, exec comp and routine governance items
FY2025 10-K: GWP $2.0B, NI $197M, $150M buyback authorization in place
Reg FD investor presentation/update with supporting exhibits
Q4/FY2025 earnings: revenue +58%, net income +68%, EPS $7.17
Closed FIA acquisition with related financing; expands surety platform
Sources: SEC EDGAR (CIK 0001761312, latest 10-Q filed 2026-05-08) · EODHD · analysis by claude-code · as of 6/25/2026, 1:49:37 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 2 sales
| 2026-06-22 | Armstrong Mac CEO and Chairman | Sell | 2.00K @ $112.72 | $226K |
| 2026-06-22 | Armstrong Mac CEO and Chairman | Sell | 1.50K @ $113.28 | $169K |
| 2026-06-02 | Notaras Martha Director | Exercise | 1.72K @ $58.06 | $100.0K |
| 2026-05-21 | Taketa Richard H Director | Award | 1.30K | |
| 2026-05-21 | Notaras Martha Director | Award | 1.30K | |
| 2026-05-21 | Middleton Daina Director | Award | 1.30K | |
| 2026-05-21 | Fallon Catriona M Director | Award | 1.30K | |
| 2026-05-21 | BRADLEY THOMAS A Director | Award | 1.30K | |
| 2026-05-21 | Bradley Daryl Director | Award | 1.30K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1044 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.